Profile
International Journal of Pediatrics & Neonatal Care Volume 7 (2021), Article ID 7:IJPNC-172, 7 pages
https://doi.org/10.15344/2455-2364/2021/172
Case Report
Suicidality as a Presenting Symptom of Multiple Sclerosis in an Adolescent: A Case Report and Review of the Literature

Brian P. Logarbo1*, Pat F. Bass III1, Adijat Olanrewaju2 and Sheila J. Asghar2

1Department of Internal Medicine and Pediatrics, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA
2Department of Pediatrics, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA
Dr. Brian P. Logarbo, Department of Internal Medicine and Pediatrics, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA, Telephone: (985) 966-2918 Fax: (830) 239-9937; E-mail: blogar@lsuhsc.edu
14 January 2021; 06 February 2021; 08 February 2021
Logarbo BP, Bass III PF, Olanrewaju A, Asghar SJ (2021) Suicidality as a Presenting Symptom of Multiple Sclerosis in an Adolescent: A Case Report and Review of the Literature. Int J Pediatr Neonat Care 7: 172. doi: https://doi.org/10.15344/2455-2364/2021/172

References

  1. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, et al. (2018) Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria. Lancet Neurol 17: 162-173. [CrossRef] [Google Scholar] [PubMed]
  2. GBD 2016 Multiple Sclerosis Collaborators (2019) Global, Regional, and National Burden of Multiple Sclerosis 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 18: 269-285. [CrossRef] [Google Scholar]
  3. Diaz-Olavarrieta C, Cummings JL, Velazquez J, Cadena CG (1999) Neuropsychiatric Manifestations of Multiple Sclerosis. J Neuropsychiatry Clin Neurosci 11: 51-57. [CrossRef] [Google Scholar] [PubMed]
  4. Hurley RA, Taber KH, Zhang J, Hayman LA (1999) Neuropsychiatric Presentation of Multiple Sclerosis. J Neuropsychiatry Clin Neurosci 11: 5-7. [CrossRef] [Google Scholar] [PubMed]
  5. Asghar-Ali AA, Taber KH, Hurley RA, Hayman LA (2004) Pure Neuropsychiatric Presentation of Multiple Sclerosis. Am J Psychiatry 161: 226-231. [CrossRef] [Google Scholar] [PubMed]
  6. Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, et al. (2007) Natural History of Multiple Sclerosis with Childhood Onset. N Engl J Med 356: 2603-2613. [CrossRef] [Google Scholar] [PubMed]
  7. Weisbrot DM, Ettinger AB, Gadow KD, Belman AL, MacAllister WS, et al. (2010) Psychiatric Comorbidity in Pediatric Patients with Demyelinating Disorders. J Child Neurol 25: 192-202. [CrossRef] [Google Scholar] [PubMed]
  8. Silveira C, Guedes R, Maia D, Curral R, Coelho R, et al. (2019) Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art. Psychiatry Investig 16: 877-888. [CrossRef] [Google Scholar] [PubMed]
  9. Persson R, Lee S, Yood MU, Wagner MR, Minton N, et al. (2020) Incident Depression in Patients Diagnosed with Multiple Sclerosis: a Multi‐Database Study. European Journal of Neurology 27: 1556-1560. [CrossRef] [Google Scholar]
  10. Krishnan KRR (2005) Psychiatric and Medical Comorbidities of Bipolar Disorder. Psychosom Med 67: 1-8. [CrossRef] [Google Scholar] [PubMed]
  11. Marangoni C, Nanni MG, Grassi L, Faedda GL, et al. (2015) Bipolar Disorder Preceding the Onset of Multiple Sclerosis. Neuroimmunology and Neuroinflammation 2: 195. [CrossRef] [Google Scholar]
  12. Stevens JR (1988) Schizophrenia and Multiple Sclerosis. Schizophrenia Bulletin 14: 231-241. [CrossRef] [Google Scholar]
  13. Arneth B (2017) Multiple Sclerosis and Schizophrenia. Int J Mol Sci 18: 1760. [CrossRef] [Google Scholar] [PubMed]
  14. Haussleiter IS, Brüne M, Juckel G (2009) Psychopathology in Multiple Sclerosis: Diagnosis, Prevalence and Treatment. Ther Adv Neurol Disord 2: 13-29. [CrossRef] [Google Scholar] [PubMed]
  15. Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrios-Morales I, Ionete C, et al. (2017) The Varieties of Psychosis in Multiple Sclerosis: A Systematic Review of Cases. Mult Scler Relat Disord 12: 9-14. [CrossRef] [Google Scholar] [PubMed]
  16. Grant SM, Diana F (1992) Oxcarbazepine. A Review of Its Pharmacology and Therapeutic Potential in Epilepsy, Trigeminal Neuralgia and Affective Disorders. Drugs 43: 873-888. [CrossRef] [PubMed]
  17. Munshi KR, Oken T, Guild DJ, Trivedi HK, Wang BC, et al. (2010) The Use of Antiepileptic Drugs (AEDs) for the Treatment of Pediatric Aggression and Mood Disorders. Pharmaceuticals (Basel) 3: 2986-3004. [CrossRef] [Google Scholar] [PubMed]
  18. Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, et al. (2006) A Double-Blind, Randomized, Placebo-Controlled Trial of Oxcarbazepine in the Treatment of Bipolar Disorder in Children and Adolescents. Am J Psychiatry 163: 1179-1186. [CrossRef] [Google Scholar] [PubMed]
  19. Leweke FM, Gerth CW, Koethe D, Faulhaber J, Klosterkotter J, et al. (2004) Oxcarbazepine as an Adjunct for Schizophrenia. Am J Psychiatry 161: 1130-1131. [CrossRef] [PubMed]
  20. Antiepileptic Drugs and Suicidality. [View]
  21. Gibbons RD, Hur K, Brown CH, Mann JJ (2009) Relationship between Antiepileptic Drugs and Suicide Attempts in Patients With Bipolar Disorder. Arch Gen Psychiatry 66: 1354-1360. [CrossRef] [Google Scholar] [PubMed]
  22. Solaro C, Brichetto G, Battaglia MA, Uccelli MM, Mancardi GL, et al. (2005) Antiepileptic Medications in Multiple Sclerosis: Adverse Effects in a Three-Year Follow-up Study. Neurol Sci 25: 307-310. [CrossRef] [Google Scholar] [PubMed]